Dyne Therapeutics Inc. (DYN) – FDA
-
Dyne Therapeutics (DYN) Climbs 100% Following Positive Initial Clinical Data from ACHIEVE Trial in DM1 Patients and DELIVER Trial Data
-
Dyne Therapeutics (DYN) Granted FDA Orphan Drug Designation for DYNE-101
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to DYN Stock Lookup